Zerit and Concomitant disease progression - a phase IV clinical study of FDA data
Summary:
Concomitant disease progression is reported as a side effect among people who take Zerit (stavudine), especially for people who are male, 40-49 old, also take Retrovir,.
The phase IV clinical study analyzes which people have Concomitant disease progression when taking Zerit. It is created by eHealthMe based on reports of 9,900 people who have side effects when taking Zerit from the FDA, and is updated regularly.
What is Zerit?
Zerit has active ingredients of stavudine. eHealthMe is studying from 9,912 Zerit users. Check the latest studies of Zerit.
What is Concomitant disease progression?
Concomitant disease progression (progress in accompanying disease) is found to be associated with 372 drugs and 622 conditions by eHealthMe. Check the latest studies of Concomitant disease progression.
9,900 people reported to have side effects when taking Zerit.
Among them, 15 people (0.15%) have Concomitant disease progression.

Among these 15 people:
What is the gender of people who have Concomitant disease progression when taking Zerit? *
- female: 20 %
- male: 80 %
What is the age of people who have Concomitant disease progression when taking Zerit? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
What are other drugs people take besides Zerit? *
- Norvir: 15 people, 100.00%
- Retrovir: 15 people, 100.00%
- Zometa: 13 people, 86.67%
- Revlimid: 13 people, 86.67%
- Flumadine: 13 people, 86.67%
- Intelence: 13 people, 86.67%
- Isentress: 13 people, 86.67%
- Kaletra: 13 people, 86.67%
- Lipitor: 13 people, 86.67%
- Zetia: 13 people, 86.67%
What are other side effects people have besides Concomitant disease progression? *
- Kidney Stones: 13 people, 86.67%
- Metastases To Spine (cancer spreads to spine): 13 people, 86.67%
- Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 13 people, 86.67%
- Wax Blockage: 13 people, 86.67%
- Hypoaesthesia (reduced sense of touch or sensation): 13 people, 86.67%
- Hypoacusis (loss of hearing): 13 people, 86.67%
- Hyperglycemia (high blood sugar): 13 people, 86.67%
- High Blood Pressure: 13 people, 86.67%
- High Blood Cholesterol: 13 people, 86.67%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 13 people, 86.67%
* Approximation only. Some reports may have incomplete information.
Do you take Zerit and have Concomitant disease progression?
- Check whether Concomitant disease progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Zerit:
- Zerit (9,912 reports)
Concomitant disease progression treatments and more:
- Concomitant disease progression (3,142 reports)
How severe was Concomitant disease progression and when was it recovered:
Expand to all the drugs that have ingredients of stavudine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zerit:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Concomitant disease progression:
- Concomitant disease progression (372 drugs)
Browse all the conditions that are associated with Concomitant disease progression:
- Concomitant disease progression (622 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on stavudine (the active ingredients of Zerit) and Zerit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Methotrexate and Belsomra - 26 seconds ago
- Could Platinol cause Abdominal Pain? - 28 seconds ago
- Could Flecainide Acetate cause Memory Loss? - 28 seconds ago
- Could Purinethol cause Constipation? - 32 seconds ago
- Could Ketotifen Fumarate cause Eye Pain? - 36 seconds ago
- Could Phenytoin cause Paleness? - 41 seconds ago
- Drug interactions of Latanoprost and Naltrexone - 41 seconds ago
- Drug interactions of Centrum and Santyl - 43 seconds ago
- Drug interactions of Captopril and Trulicity - 43 seconds ago
- Could Turmeric cause Tremor? - a minute ago